Tandem Diabetes (TNDM) Misses Q3 EPS by 3c

Tandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of ($0.51), $0.03 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $185.6 million versus the consensus estimate of $192.89 million.

For earnings history and earnings-related data on Tandem Diabetes (TNDM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge